A major new Lancet Commission has called for people taking psychiatric medications – such as antidepressants, antipsychotics, and mood stabilisers – to receive proactive, ongoing physical health monitoring and support….
Findings from a study published today in The Lancet Public Health provide the strongest evidence to date that salt warning labels on restaurant menus are perceived by consumers as effective…
A new study has investigated whether cannabidiol (CBD), a non-intoxicating compound found in cannabis, can reduce the harmful effects of cannabis use in people with schizophrenia. The study, “Does cannabidiol…
Corina Cheeks holds an important role with both our BRC and the NIHR Oxford Biomedical Research Centre (Oxford BRC) Corina is a Public Contributor in the OH BRC’s Data Science…
Congratulations to Oxford Health Biomedical Research Centre (OH BRC) Data Science Theme researcher and University of Oxford Honorary Senior Clinical Research Fellow Dr Howard Ryland who has received the NIHR…
Developing cardiovascular, mental health and neurological-related illnesses before the age of 70 is associated with a greater risk of dementia later in life, with the more of these conditions accumulated…
The UK Clinical Research Facility (UKCRF) Network celebrated a milestone this July with its 20th Annual Conference, held for the first time in partnership with the National Institute for Health…
A new review published in JAMA Psychiatry explores how inflammation in the body may contribute to mental health conditions such as psychosis, depression and autism, and what this could mean for…
We would like to congratulate Dr Jane Quinlan, Consultant in Anaesthetics and Pain Management at Oxford University Hospitals NHS FT and OH BRC researcher in our Pain Theme, who has…
Recently, the NIHR Oxford Health Biomedical Research Centre’s Mental Health in Development (MHID) Theme Meeting bought together researchers, clinicians, and collaborators at New Radcliffe House. The event showcased the MHID…
British Association for Psychopharmacology (BAP) is a UK-based scientific society that promotes research and education in psychopharmacology—the study of how drugs affect mood, behaviour and mental processes. BAP supports both…
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford….
Recent developments in psychiatry and neuroscience are shedding light on the potential of digital and pharmacological innovations to transform mental health care. Two new significant studies from the University of…
A new study by the University of Oxford published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in…
The successful parent-led programme, developed with support from the NIHR Oxford Health Biomedical Research Centre (OH BRC) and the Applied Research Collaboration Oxford and Thames Valley (ARC OxTV), is being…
Statins deemed safe from a neuropsychiatric perspective but ineffective as antidepressants in at-risk adults, Oxford study finds. A landmark online trial published in Psychological Medicine and conducted at the University…
Researchers from Oxford’s two NIHR Biomedical Research Centres (BRC) took over the city’s Westgate Centre on Thursday 29 May for their annual Health Research Showcase. Hundreds of half-term visitors, including…
What happens when the last known habitat for an endangered species stands in the way of vital human development? Last Haven, a study led by researchers at the University of…
Oxford Health Biomedical Research Centre (OH BRC) is excited to announce an academic opportunity for Nurses, Midwives, and Allied Health Professionals (NMAHPs) connected with organisations in the Buckinghamshire, Oxfordshire and…
A Joint Effort by Oxford Health BRC and the University of Oxford Department of Psychiatry. Mental Health Awareness Week is an annual event that highlights the importance of mental well-being…